Evidence map›Paper›PMID 19394426›Full record

ArticleMolecular and cellular neurosciences2009

Knockdown and overexpression of NR1 modulates NMDA receptor function.

Maggie L Kalev-Zylinska, Wymond Symes, Deborah Young, Matthew J During

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Functional Analysis of the 3' Untranslated Region of the HumanNeuropsychiatric disease and treatment · 2020
    Article
  8. Article
  9. NMDAR Hypofunction Animal Models of Schizophrenia.Frontiers in molecular neuroscience · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Maggie L Kalev-ZylinskaDepartment of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.
Wymond Symes
Deborah Young
Matthew J During
University of Auckland · NZThe Ohio State University · US

Funding

Somatic Cell Gene Transfer/Neurological & Clinical ApplicationsR01NS044576 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI LIN, EN-JU · 2004 to 2013
$3.3M
NINDS NIH HHS R01 NS044576NINDS NIH HHS R01 NS44576
6 · The paper itself

Abstract

The N-methyl-d-aspartate receptor (NMDAR) is critically involved in learning and memory, neuronal survival, as well as neuroexcitotoxicity and seizures. We hypothesize that even mild reductions in the numbers of hippocampal NMDARs could impair learning and memory, whereas increasing receptor activity would facilitate learning but reduce seizure threshold. We developed novel gene transfer strategies assisted by an adeno-associated viral vector 1/2 to bi-directionally modulate expression levels of the NR1 protein in rat hippocampus. Functional consequences of the altered NR1 expression were examined in the acute seizure model, and on normal processes of fear memory and neurogenesis. We found that knocking down NR1 protected against seizures at the expense of impaired learning, as predicted. Paradoxically, NR1 overexpression not only increased fear memory and neurogenesis, but also delayed onset of more severe seizures. In conclusion, the observed consequences of NR1 knockdown and overexpression underscore NMDAR requirement for neuronal plasticity, and are in agreement with its dichotomous functions.

Indexed as

Analysis of VarianceAnimalsBehavior, AnimalBromodeoxyuridineCell Line, TransformedDisease Models, AnimalExcitatory Amino Acid AgonistsFearFlow CytometryGene ExpressionGene Expression RegulationGene Knockdown TechniquesGreen Fluorescent ProteinsHippocampusHumansKainic AcidBromodeoxyuridineExcitatory Amino Acid AgonistsGreen Fluorescent ProteinsKainic AcidLuminescent ProteinsNR1 NMDA receptorReceptors, N-Methyl-D-AspartateRNA, Small Interfering

Identifiers

PMID19394426
PMCPMC3727896
OpenAlexW2000360198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.